Lung Cancer Diagnostics Market (2025 - 2033) Size, Share & Trends Analysis Report By Type (Small Cell Lung Cancer, Non-Small Cell Lung Cancer), By Test (CA Tests, HER2 Tests, ALK Tests), By End Use, Region And Segment Forecasts

Market Segmentation

• Lung Cancer Diagnostics Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Non-small cell lung cancer
  • Small cell lung cancer
• Lung Cancer Diagnostics Test Outlook (Revenue, USD Million, 2021 - 2033)
  • CA test
  • HER2 test
  • ALK test
  • Angiogenesis Inhibitors
  • EGFR Mutation test
  • KRAS Mutation test
• Lung Cancer Diagnostics End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Laboratories
  • Others
• Lung Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • North America Lung Cancer Diagnostics Market, By Type
      • Non-small cell lung cancer
      • Small cell lung cancer
    • North America Lung Cancer Diagnostics Market, By Test
      • CA test
      • HER2 test
      • ALK test
      • Angiogenesis Inhibitors
      • EGFR Mutation test
      • KRAS Mutation test
    • North America Lung Cancer Diagnostics Market, By End Use
      • Hospitals
      • Laboratories
      • Others
    • U.S.
      • U.S. Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • U.S. Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • U.S. Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Canada
      • Canada Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Canada Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Canada Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Mexico
      • Mexico Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Mexico Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Mexico Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
  • Europe
    • Europe Lung Cancer Diagnostics Market, By Type
      • Non-small cell lung cancer
      • Small cell lung cancer
    • Europe Lung Cancer Diagnostics Market, By Test
      • CA test
      • HER2 test
      • ALK test
      • Angiogenesis Inhibitors
      • EGFR Mutation test
      • KRAS Mutation test
    • Europe Lung Cancer Diagnostics Market, By End Use
      • Hospitals
      • Laboratories
      • Others
    • UK
      • UK Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • UK Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • UK Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Germany
      • Germany Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Germany Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Germany Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • France
      • France Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • France Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • France Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Italy
      • Italy Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Italy Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Italy Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Spain
      • Spain Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Spain Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Spain Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Norway
      • Norway Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Norway Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Norway Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Denmark
      • Denmark Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Denmark Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Denmark Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Sweden
      • Sweden Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Sweden Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Sweden Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
  • Asia Pacific
    • Asia Pacific Lung Cancer Diagnostics Market, By Type
      • Non-small cell lung cancer
      • Small cell lung cancer
    • Asia Pacific Lung Cancer Diagnostics Market, By Test
      • CA test
      • HER2 test
      • ALK test
      • Angiogenesis Inhibitors
      • EGFR Mutation test
      • KRAS Mutation test
    • Asia Pacific Lung Cancer Diagnostics Market, By End Use
      • Hospitals
      • Laboratories
      • Others
    • Japan
      • Japan Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Japan Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Japan Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • China
      • China Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • China Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • China Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • India
      • India Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • India Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • India Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Australia
      • Australia Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Australia Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Australia Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • South Korea
      • South Korea Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • South Korea Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • South Korea Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Thailand
      • Thailand Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Thailand Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Thailand Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
  • Latin America
    • Latin America Lung Cancer Diagnostics Market, By Type
      • Non-small cell lung cancer
      • Small cell lung cancer
    • Latin America Lung Cancer Diagnostics Market, By Test
      • CA test
      • HER2 test
      • ALK test
      • Angiogenesis Inhibitors
      • EGFR Mutation test
      • KRAS Mutation test
    • Latin America Lung Cancer Diagnostics Market, By End Use
      • Hospitals
      • Laboratories
      • Others
    • Brazil
      • Brazil Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Brazil Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Brazil Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Argentina
      • Argentina Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Argentina Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Argentina Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
  • MEA
    • MEA Lung Cancer Diagnostics Market, By Type
      • Non-small cell lung cancer
      • Small cell lung cancer
    • MEA Lung Cancer Diagnostics Market, By Test
      • CA test
      • HER2 test
      • ALK test
      • Angiogenesis Inhibitors
      • EGFR Mutation test
      • KRAS Mutation test
    • MEA Lung Cancer Diagnostics Market, By End Use
      • Hospitals
      • Laboratories
      • Others
    • South Africa
      • South Africa Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • South Africa Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • South Africa Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Saudi Arabia
      • Saudi Arabia Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Saudi Arabia Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Saudi Arabia Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • UAE
      • UAE Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • UAE Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • UAE Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others
    • Kuwait
      • Kuwait Lung Cancer Diagnostics Market, By Type
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Kuwait Lung Cancer Diagnostics Market, By Test
        • CA test
        • HER2 test
        • ALK test
        • Angiogenesis Inhibitors
        • EGFR Mutation test
        • KRAS Mutation test
      • Kuwait Lung Cancer Diagnostics Market, By End Use
        • Hospitals
        • Laboratories
        • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2021 to 2033
• Market estimates and forecast for product segments up to 2033
• Regional market size and forecast for product segments up to 2033
• Market estimates and forecast for application segments up to 2033
• Regional market size and forecast for application segments up to 2033
• Company financial performance